Showing results (2241-2250 of 3,052) with videos related to

Sort By:
Pageof 306
Journal of Bacteriology|May 9, 2018
Disruption of a Novel Iron Transport System Reverses Oxidative Stress Phenotypes of a dpr Mutant Strain of Streptococcus mutansTridib Ganguly, Jessica K Kajfasz, James H Miller, et al.
FEMS Microbiology Letters|June 19, 2018
Distribution of Staphylococcus species in dairy cows, workers and shared farm environmentsMarilyn C Roberts, Gemina Garland-Lewis, Sally Trufan, et al.
Clinical and Experimental Immunology|December 12, 2001
Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS)A Katzav, Y Kloog, A D Korczyn, et al.
Neuroscience Letters|February 25, 2000
The deletion polymorphism and Val1000Ile in alpha-2-macroglobulin and Alzheimer disease in Caribbean HispanicsS N Romas, R Mayeux, D Rabinowitz, et al.
The Journal of Clinical Investigation|February 1, 1977
Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal manJ E Liljenquist, G L Mueller, A D Cherrington, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectorsLingling Du, Masakuni Kido, Darwin V Lee, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2008
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumorsClaire F Verschraegen, Keith Skubitz, Adil Daud, et al.
Neuroimage. Clinical|June 1, 2024
Sleep and physical activity measures are associated with resting-state network segregation in non-demented older adultsDaniel D Callow, Adam P Spira, Vadim Zipunnikov, et al.
Health Affairs Scholar|May 17, 2024
Access challenges for patients with limited English proficiency: a secret-shopper study of in-person and telehealth behavioral health services in California safety-net clinicsLori Uscher-Pines, Kandice Kapinos, Claudia Rodriguez, et al.
The American Journal of Psychiatry|July 29, 2017
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in SchizophreniaMichael Davidson, Jay Saoud, Corinne Staner, et al.
Pageof 306